logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yuming Zhu

Chongqing Medical University
H指数:29
被引数:3,033

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The trajectory of frailty index and its association with rapid decline in kidney function and the incidence of chronic kidney disease: evidence from the China health and retirement longitudinal study

衰弱指数的轨迹及其与肾功能快速下降和慢性肾脏病发生的关系：来自中国健康与养老追踪研究的证据

Aging Clinical and Experimental Research
IF3.4
2025-08-020
OAAI
Wei-Zhen Tang; Bo-Yuan Deng; Qin-Yu Cai; Yong-Heng Wang; Qin-Hao Yang; Hong-Yu Xu; Wang Qi Rui Liu; Tai-Hang Liu; Fei Han; Yu-Ming Zhu
Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial

不可切除III期EGFR突变非小细胞肺癌的新辅助奥莫替尼治疗：一项单臂II期试验

NATURE COMMUNICATIONS
IF15.7
2025-04-021
OA
Bian, Dongliang; Ji, Shuyu; Liu, Yue; Huang, Zhida; Jiang, Lei; Liu, Ming; Bao, Xiao; Yang, Jie; Zhou, Yirui; Hu, Junjie; Sun, Liangdong; Zheng, Yingzhi; Huang, Jie; Liu, Jing; Zhu, Xinsheng; Zhang, Jing; Zhang, Lele; Liu, Xiaogang; He, Wenxin; Xie, Dong; Zhu, Yuming; Wu, Chunyan; Zhao, Deping; Duan, Liang; Jiang, Gening; Zhang, Peng
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

新辅助PD-1抑制剂 (toripalimab) 联合化疗治疗 ⅱ-ⅲ 期NSCLC的安全性和有效性 (LungMate 002): 一项开放标签、单臂、2期试验

BMC MEDICINE
IF8.3
2022-12-3029
OAAI
Zhu, Xinsheng; Sun, Liangdong; Song, Nan; He, Wenxin; Xie, Boxiong; Hu, Junjie; Zhang, Jing; Yang, Jie; Dai, Jie; Bian, Dongliang; Xia, Haoran; Sun, Fenghuan; Xiong, Anwen; Luo, Jie; Zhang, Lele; Yu, Huansha; Liu, Ming; Liu, Hongcheng; Wang, Haifeng; Zhang, Haiping; Chen, Chang; Wu, Chunyan; Duan, Liang; Zhu, Yuming; Zhang, Peng; Jiang, Gening

研究方向

暂未获取到该数据
G
Gening Jiang
H 指数:53论文数:561被引数:1.1万
D
Dong Xie
H 指数:44论文数:479被引数:8,067
Y
Yunlang She
H 指数:3论文数:12被引数:132
赵德平 封面图
赵德平
H 指数:20论文数:97被引数:1,232
Y
Yunlang She
H 指数:32论文数:129被引数:3,297
L
Liang Duan
H 指数:28论文数:116被引数:2,542
戴洁 封面图
戴洁
H 指数:29论文数:196被引数:3,542
何文新 封面图
何文新
H 指数:22论文数:124被引数:1,564
张鹏 封面图
张鹏
H 指数:52论文数:384被引数:1.1万
C
Chang Chen
H 指数:37论文数:311被引数:7,539